The evaluation of gold-based compounds as potential inhibitors of HIV-1 replication.
Highly active antiretroviral therapy has successfully limited HIV-1 disease progression to AIDS, but is consistently compromised by the emergence and transmission of HIV-1 drug resistant strains. As a result, a continued search for novel anti-HIV-1 agents with improved pharmacological profiles ha...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2012
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10539/11030 |